Dr. Victor Ling, PHD, O.C., O.B.C.

President and Scientific DirectorBoard of Directors member

Dr. Victor Ling is the founding president and scientific director of TFRI. He is an authority on multi-drug resistance in cancer and is well-known for his discovery of P-glycoprotein, the first molecule identified to be responsible for drug resistance. Dr. Ling was the vice-president of discovery research at the BC Cancer Agency. Dr. Ling provides overall leadership to TFRI, the development of translational research, relationships with stakeholders, and TFRI communications.